- Interesting Late Stage Viral Vaccine CandidatesPosted 12 days ago
- From Product Candidate to Product: The Road to Commercialization in Regenerative MedicinePosted 34 days ago
- Part III – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 41 days ago
- Part II – Fifteen Cell Therapies/Stem Cell Therapies in Phase III Clinical TrialsPosted 48 days ago
- Fifteen Cell and Stem Cell Therapies in Phase III Clinical Trials – Part IPosted 54 days ago
- Biologics Have a Robust Pipeline According to Latest PhRMA ReportPosted 61 days ago
- Biologics Take Top Spots in Best Selling Drugs of 2012Posted 68 days ago
- Best Practices in Cell Therapy ManufacturingPosted 104 days ago
- Can Stable Expression Levels be Achieved in a Transient Expression System – Expi293Posted 117 days ago
- Identifying Options for Stem Cell Based Therapy Scale-upPosted 135 days ago
The Dish’s Weekly News Wrap Up – August 31, 2012
This week’s headlines include, Appeals Court rules on embryonic stem cell research, Top 25 Biotechs, innovative stem cell therapy developments, a new influenza vaccine study and Roche’s breast cancer drug promises longer survival. Cell Culture Events: Attend...
- Posted August 31, 2012
Defined Supplements – The Role of Recombinant Proteins in Biopharmaceutical Manufacturing
Defined supplements that improve growth, productivity and consistency are highly attractive for cell culture optimization projects. And, recombinant proteins are increasingly being used as defined supplements in biopharmaceutical, vaccine and stem cell manufacturing. The use of recombinant...
- Posted August 28, 2012
The Dish’s Weekly News Wrap Up – August 24, 2012
This week’s headlines include, innovative stem cell therapy trials, another vaccination success story, new breast cancer drug report, Myriad wins gene patent ruling, and the advantages of targeting rare diseases. “Chicken Pox Cases Fall 80% Over Decade:...
- Posted August 24, 2012
Venture Capital Investment in the Life Science Sector is Down for 2012 – Is There a Light at the End of the Tunnel?
Venture capital investment in the life science sector is down both in total number of venture dollars and number of deals according to the Dollar Drought Moneytree Life Sciences Report, published this month by Price Waterhouse Cooper....
- Posted August 23, 2012
The Dish’s Weekly News Wrap Up – August 17, 2012
This week’s headlines include, influenza and ebola vaccine developments, investment updates, the latest business deals, researchers get one step closer to regenerating the human heart and a new study shows promising results for use of an existing...
- Posted August 17, 2012